CAMBRIDGE, Massachusetts and TORONTO, Ontario, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a biotechnology company focused on the generation and development of therapeutics ...

CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody ...

The World Neuroscience Day Conference champions learning, empowerment, and community connection for those affected by neurological disorders. Through education, storytelling, and shared experience, ...

Jupiter Neurosciences is a B2i Digital Featured Company. See the company’s profile at At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. In November 2025, ...

A Global Online Event to Explore Yoga's Impact on Migraine, Child Development, Neurodiversity, Brain Longevity and Healthy ...

JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...

The annual Society for Neuroscience (SfN) conference is currently underway in Chicago. Thousands of neuroscientists have gathered here to discuss the latest topics in neuroscience research. They’re ...

ProMIS Neurosciences Inc., a clinical-stage biotechnology firm, announced its plan to present preclinical data on novel computationally-derived vaccines targeting neurodegenerative diseases at the ...

Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience Institute and Foundation proudly announce the 2026 World Neuroscience Day ...